Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10

BORIS DOI
Publisher DOI
PubMed ID
30559073
Date of Publication
2019-03
Publication Type
Article
Subject(s)
Language(s)
en
Contributor(s)
Kienle, Dirk L.
Dietrich, Daniel
Ribi, Karin
Wicki, Andreas
Quagliata, Luca
Winterhalder, Ralph C.
Koeberle, Dieter
Horber, Daniel
Bastian, Sara
Kueng, Marc
Saletti, Piercarlo
Helbling, Daniel
Baertschi, Daniela
Andrieu, Christiane
von Moos, Roger
Additional Credits
Series
Journal of geriatric oncology
Publisher
Elsevier
ISSN
1879-4068
Access(Rights)
restricted
Show full item